Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01858948
What this trial is testing

SGA-induced Metabolic Syndrome in Bipolar Youth

Who this might be right for
Bipolar Youth Treated With Second-generation Antipsychotics
University of Cincinnati 19
Not applicableStudy completedNCT00283517
What this trial is testing

A Registry of Treatment Adherence for Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen-Cilag, S.A. 2,046
Not applicableUnknownNCT04010864
What this trial is testing

Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

Who this might be right for
Clinical High-risk
Shanghai Mental Health Center 600
Post-approval studies (Phase 4)Study completedNCT00306475
What this trial is testing

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 60
Post-approval studies (Phase 4)Study completedNCT01670019
What this trial is testing

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

Who this might be right for
Major Depressive Disorder Without Psychotic Features
Duke University 46
Not applicableWithdrawnNCT05939765
What this trial is testing

Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

Who this might be right for
Schizophrenia
Psychiatric University Hospital, Zurich
Post-approval studies (Phase 4)Study completedNCT00205699
What this trial is testing

Metabolic Effects of Antipsychotics in Children

Who this might be right for
AggressionAttention Deficit-HyperactivityOppositional Defiant Disorder+2 more
Washington University School of Medicine 144
Testing effectiveness (Phase 2)Ended earlyNCT02820519
What this trial is testing

Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

Who this might be right for
Neuropathic Pain
University of Witten/Herdecke 4
Large-scale testing (Phase 3)Study completedNCT01825798
What this trial is testing

Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)

Who this might be right for
OverweightAutism Spectrum Disorder
Holland Bloorview Kids Rehabilitation Hospital 60
Not applicableEnded earlyNCT01867398
What this trial is testing

Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders

Who this might be right for
Conduct DisorderfMRI
National Institute of Mental Health (NIMH) 12
Not applicableStudy completedNCT00344500
What this trial is testing

Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

Who this might be right for
DiabetesObesityWeight Gain
VA Office of Research and Development 122
Post-approval studies (Phase 4)WithdrawnNCT02213887
What this trial is testing

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Who this might be right for
Psychotic DisordersGastroesophageal Reflux
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT00628290
What this trial is testing

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

Who this might be right for
Schizophrenia
University of Cologne 42
Not applicableUnknownNCT00752960
What this trial is testing

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

Who this might be right for
Psychoses
Genomas, Inc 1,000
Large-scale testing (Phase 3)Study completedNCT00535574
What this trial is testing

Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia

Who this might be right for
Schizophrenia
Beersheva Mental Health Center 90
Testing effectiveness (Phase 2)Study completedNCT00175955
What this trial is testing

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Who this might be right for
Dyskinesia, Medication-induced
UCB Pharma 70
Not applicableStudy completedNCT00392743
What this trial is testing

Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

Who this might be right for
Schizophrenia
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00692185
What this trial is testing

Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

Who this might be right for
Eating Disorders
New York State Psychiatric Institute 23
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Large-scale testing (Phase 3)Study completedNCT00236587
What this trial is testing

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100
Next Page